Compare INLX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INLX | TXMD |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 24.3M |
| IPO Year | 2013 | 2012 |
| Metric | INLX | TXMD |
|---|---|---|
| Price | $5.15 | $2.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.7K | ★ 17.3K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | $11,336.00 | ★ $1,761,000.00 |
| Revenue This Year | $14.57 | $207.74 |
| Revenue Next Year | N/A | $2.15 |
| P/E Ratio | ★ N/A | $102.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $5.00 | $0.99 |
| 52 Week High | $11.75 | $2.95 |
| Indicator | INLX | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.02 |
| Support Level | N/A | $2.00 |
| Resistance Level | N/A | $2.15 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 0.00 |
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.